Published in
Elsevier, The Lancet Infectious Diseases, 2023
DOI: 10.1016/s1473-3099(23)00067-1
Links
Tools
Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial
Journal article published in 2023 by
Gail B. Cross,
Intan P. Sari,
Cissy Kityo 
,
Qingshu Lu,
Yogesh Pokharkar,
Rajesh B. Moorakonda,
Han-Nguyen Thi,
Quyet Do,
Victoria B. Dalay,
Emmanuel Gutierrez,
Vincent M. Balanag,
Randy J. Castillo,
Henry Mugerwa,
Felic Fanusi,
Philip Kwan
and other authors.
,
Qingshu Lu,
Yogesh Pokharkar,
Rajesh B. Moorakonda,
Han-Nguyen Thi,
Quyet Do,
Victoria B. Dalay,
Emmanuel Gutierrez,
Vincent M. Balanag,
Randy J. Castillo,
Henry Mugerwa,
Felic Fanusi,
Philip Kwan
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 